These recombinant collectins could replace the deficient immunomodulatory host proteins SP-A and SP-D in the premature neonatal lung and prevent the development of neonatal chronic lung disease with associated respiratory and neurological complications (Clark, 2010). Here, SFTPA2 is linked to chronic lung disease.